Healthcare Realty Trust Inc (HR) stock
Close on Oct 29, 2026Market cap $6.21BP/E –Yield 6.07%
Earnings
Healthcare Realty Trust's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Healthcare Realty Trust's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 11, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026after the close | $286.64M | -3.7% | -$0.05 | $0.42 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026during market hours | $281.85M | – | -$0.13 | $0.41 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026during market hours | $278.99M | -6.7% | $0.00 | $0.41 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 12, 2026during market hours | – | – | $0.04 | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025during market hours | $297.77M | -5.6% | -$0.17 | $0.41 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025during market hours | – | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025during market hours | $298.98M | -8.5% | -$0.13 | $0.39 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 19, 2025before the open | $309.77M | – | -$0.31 | $0.40 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024before the open | $315.42M | – | -$0.26 | $0.39 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 2, 2024before the open | – | – | -$0.39 | $0.38 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024before the open | $326.81M | – | -$0.82 | $0.39 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 16, 2024before the open | – | – | -$0.11 | $0.39 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 3, 2023before the open | – | – | -$0.18 | $0.39 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | – | – | -$0.22 | $0.39 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023before the open | – | – | -$0.23 | $0.40 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 1, 2023before the open | $338.06M | +72.7% | -$0.09 | $0.42 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022before the open | – | – | $0.08 | $0.39 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022before the open | – | – | $0.04 | $0.45 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022during market hours | $202.00M | – | $0.08 | $0.44 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022during market hours | $195.70M | – | $0.07 | $0.43 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 5, 2021before the open | $191.26M | – | $0.10 | $0.44 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021during market hours | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 22, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 3, 2020during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Healthcare Realty Trust's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Same Store Cash NOI growthnon-GAAP | FY2026 | +3.75% – +4.75% | +3.5% – +4.5% | Raised | Apr 30, 2026 |
| Earnings per shareGAAP | FY2026 | -$0.15 – -$0.11 | – | New | Oct 29, 2026 |
| Earnings per shareGAAP | FY2026 | -$0.15 – -$0.11 | -$0.05 – $0.05 | Lowered | Jul 30, 2026 |
| Normalized FFO per sharenon-GAAP | FY2026 | $1.65 – $1.67 | – | New | Oct 29, 2026 |
| NAREIT FFO per sharenon-GAAP | FY2026 | $1.48 – $1.52 | – | New | Oct 29, 2026 |
| NAREIT FFO per sharenon-GAAP | FY2026 | $1.45 – $1.51 | $1.45 – $1.51 | Reaffirmed | Jul 30, 2026 |
| Normalized FFO per sharenon-GAAP | FY2026 | $1.62 – $1.66 | $1.58 – $1.64 | Raised | Jul 30, 2026 |
| Same Store Cash NOI growthnon-GAAP | FY2026 | +5% – +5.25% | – | New | Oct 29, 2026 |
| Same Store Cash NOI growth | FY2026 | +4.25% – +5% | – | New | Jul 30, 2026 |
Guidance vs results
The last range Healthcare Realty Trust gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2024 | EPS (GAAP) | -$0.12 – -$0.11 | -$0.39 | Below range |
| Q2 FY2024 | Normalized FFO per share | $0.38 – $0.39 | $0.38 | Within range |
| Q1 FY2024 | EPS (GAAP) | -$0.12 – -$0.11 | -$0.82 | Below range |
| Q1 FY2024 | Normalized FFO per share | $0.38 – $0.39 | $0.39 | Within range |
Guidance history
Every forecast Healthcare Realty Trust put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Normalized FFO per share | FY2026 | $1.65 – $1.67 | New |
| Oct 29, 2026 | Earnings per share | FY2026 | -$0.15 – -$0.11 | New |
| Oct 29, 2026 | Same Store Cash NOI growth | FY2026 | +5% – +5.25% | New |
| Oct 29, 2026 | NAREIT FFO per share | FY2026 | $1.48 – $1.52 | New |
| Jul 30, 2026 | Earnings per share | FY2026 | -$0.15 – -$0.11 | Lowered |
| Jul 30, 2026 | Same Store Cash NOI growth | FY2026 | +4.25% – +5% | New |
| Jul 30, 2026 | NAREIT FFO per share | FY2026 | $1.45 – $1.51 | Reaffirmed |
| Jul 30, 2026 | Normalized FFO per share | FY2026 | $1.62 – $1.66 | Raised |
| Apr 30, 2026 | Same Store Cash NOI growth | FY2026 | +3.75% – +4.75% | Raised |
| Apr 30, 2026 | Earnings per share | FY2026 | -$0.05 – $0.05 | Reaffirmed |
| Apr 30, 2026 | NAREIT FFO per share | FY2026 | $1.45 – $1.51 | Lowered |
| Feb 12, 2026 | Same Store Cash NOI growth | FY2026 | +3.5% – +4.5% | New |
| Feb 12, 2026 | Earnings per share | FY2026 | -$0.05 – $0.05 | New |
| Feb 12, 2026 | NAREIT FFO per share | FY2026 | $1.44 – $1.50 | New |
| Feb 12, 2026 | Normalized FFO per share | FY2026 | $1.58 – $1.64 | Raised |
| Oct 30, 2025 | Normalized FFO per share | FY2025 | $1.59 – $1.61 | New |
| Oct 30, 2025 | Earnings per share | FY2025 | -$0.86 – -$0.81 | New |
| Oct 30, 2025 | Net Debt to Adjusted EBITDA | FY2025 | 5.4 – 5.7 | New |
| Oct 30, 2025 | Same Store Cash NOI growth | FY2025 | +4% – +4.75% | New |
| Oct 30, 2025 | NAREIT FFO per share | FY2025 | $1.39 – $1.41 | New |
| May 1, 2025 | Normalized FFO per share | FY2025 | $1.56 – $1.60 | Reaffirmed |
| May 1, 2025 | Earnings per share | FY2025 | -$0.28 – -$0.20 | Reaffirmed |
| May 1, 2025 | NAREIT FFO per share | FY2025 | $1.44 – $1.48 | Reaffirmed |
| Feb 19, 2025 | same store cash NOI growth | FY2025 | +3% – +3.75% | New |
| Feb 19, 2025 | Normalized FFO per share | FY2025 | $1.56 – $1.60 | New |
| Feb 19, 2025 | Earnings per share | FY2025 | -$0.28 – -$0.20 | New |
| Feb 19, 2025 | NAREIT FFO per share | FY2025 | $1.44 – $1.48 | New |
| Oct 30, 2024 | Normalized FFO per share | FY2024 | $1.55 – $1.56 | Narrowed |
| Oct 30, 2024 | Earnings per share | FY2024 | -$1.60 – -$1.59 | Lowered |
| Oct 30, 2024 | NAREIT FFO per share | FY2024 | $0.58 – $0.59 | Lowered |
| Aug 2, 2024 | Normalized FFO per share | FY2024 | $1.53 – $1.58 | Raised |
| Aug 2, 2024 | Earnings per share | FY2024 | -$1.50 – -$1.40 | Lowered |
| Aug 2, 2024 | NAREIT FFO per share | FY2024 | $0.77 – $0.82 | Reaffirmed |
| May 7, 2024 | Normalized FFO per share | Q2 FY2024 | $0.38 – $0.39 | New |
| May 7, 2024 | Normalized FFO per share | FY2024 | $1.52 – $1.58 | Reaffirmed |
| May 7, 2024 | Earnings per share | Q2 FY2024 | -$0.12 – -$0.11 | New |
| May 7, 2024 | Earnings per share | FY2024 | -$1.30 – -$0.80 | Lowered |
| May 7, 2024 | NAREIT FFO per share | Q2 FY2024 | $0.35 – $0.36 | New |
| May 7, 2024 | NAREIT FFO per share | FY2024 | $0.77 – $0.82 | Lowered |
| Feb 16, 2024 | Normalized FFO per share | Q1 FY2024 | $0.38 – $0.39 | New |
| Feb 16, 2024 | Normalized FFO per share | FY2024 | $1.52 – $1.58 | New |
| Feb 16, 2024 | Earnings per share | Q1 FY2024 | -$0.12 – -$0.11 | New |
| Feb 16, 2024 | Earnings per share | FY2024 | -$0.60 – -$0.10 | New |
| Feb 16, 2024 | NAREIT FFO per share | Q1 FY2024 | $0.35 – $0.36 | New |
| Feb 16, 2024 | NAREIT FFO per share | FY2024 | $1.42 – $1.48 | New |
| Nov 5, 2021 | Same-Property Cash NOI | FY2021 | +2% – +2.5% | New |
| Nov 5, 2021 | Normalized FFO per share | FY2021 | $1.75 – $1.77 | New |
| Nov 5, 2021 | Net income attributable to common stockholders per share | FY2021 | $0.44 – $0.48 | New |
| Nov 5, 2021 | FFO per share, as defined by NAREIT | FY2021 | $1.73 – $1.77 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Healthcare Realty Trust filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- News
- Results
- Results
- Update
- Results
- Results
- Results
- Update
- Results
- Results